HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor

Hum Immunol. 2001 Aug;62(8):809-13. doi: 10.1016/s0198-8859(01)00270-1.

Abstract

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder, in which antibodies against voltage-gated calcium channels located at nerve terminals cause muscle weakness and autonomic dysfunction. In approximately half of the patients the autoimmune process is initiated by a tumor. In the other half of patients no tumor is found and the etiology is unknown. The aims of this study were to investigate the strength of HLA-associations with nontumor LEMS (NT-LEMS) and to study the relation of HLA-haplotypes with age at onset of LEMS and other clinical features. Therefore, typing of HLA class I and II was performed in 19 patients with NT-LEMS, who were clinically evaluated. NT-LEMS was significantly associated with alleles of both HLA-class I (i.e. HLA-B8) as well as -class II (i.e. HLA-DR3 and -DQ2). HLA-B8+ patients had significantly younger age at onset of LEMS and tended to be female. This study shows that HLA-class I haplotype is associated with a distinct phenotype in NT-LEMS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Child
  • Female
  • Histocompatibility Antigens Class I / classification*
  • Histocompatibility Antigens Class II / classification*
  • Histocompatibility Testing
  • Humans
  • Lambert-Eaton Myasthenic Syndrome / immunology*
  • Male
  • Middle Aged

Substances

  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II